This indicates that safranal’s inhibitory effect on glioma is most likely to be achieved by inhibiting the PI3K/Akt/mTOR axis, acting on apoptosis-related proteins to increase tumour cell apoptosis, and acting on cycle-related proteins to regulate the tumour cell cycle. This evidence concerns the gene AKT1 and central nervous system cancer.